Skip to main content

Institutional filer profile

Orbimed Advisors LLC Insider Trades

Latest reported as Corporate insider of ADARx Pharmaceuticals, Inc. (ADRX).

Purchase filings
8
Reported companies
10
Net open-market value
$24,974,032
Latest transaction
Sep 28, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 28, 2026ADARx Pharmaceuticals, Inc. (ADRX)Corporate insiderOpen Market Purchase950,000$17.00$16,150,000
Sep 21, 2026Electra Therapeutics, Inc. (ETRA)Corporate insiderOpen Market Purchase1,333,333$15.00$19,999,995
Aug 10, 2026BlossomHill Therapeutics, Inc. (BLSM)Corporate insiderOpen Market Purchase625,000$16.00$10,000,000
Aug 7, 2026Braveheart Bio, Inc. (BRVE)Corporate insiderOpen Market Purchase1,940,000$18.00$34,920,000
Jul 27, 2026Scribe Therapeutics, Inc. (SCTX)Corporate insiderOpen Market Purchase1,000,000$15.00$15,000,000
Jul 7, 2026Sionna Therapeutics, Inc. (SION)Corporate insiderSale85,918$44.86$3,854,281
Jun 30, 2026Sionna Therapeutics, Inc. (SION)Corporate insiderSale115,844$45.50$5,270,902
Jun 22, 2026Enliven Therapeutics, Inc. (ELVN)Corporate insiderSale860,123$45.36$39,014,061
Jun 15, 2026Enliven Therapeutics, Inc. (ELVN)Corporate insiderSale281,408$45.02$12,668,988
May 28, 2026Q32 Bio Inc. (QTTB)Corporate insiderOpen Market Purchase1,875,000$8.00$15,000,000